Inhibition of Histone Lysine-specific Demethylase 1 Elicits Breast Tumor Immunity and Enhances Antitumor Efficacy of Immune Checkpoint Blockade

Immunotherapy strategies have been emerging as powerful weapons against cancer. Early clinical trials reveal that overall response to immunotherapy is low in breast cancer patients, suggesting that effective strategies to overcome resistance to immunotherapy are urgently needed. In this study, we in...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncogene
Main Authors: Qin, Ye, Vasilatos, Shauna N., Chen, Lin, Wu, Hao, Cao, Zhishen, Fu, Yumei, Huang, Min, Vlad, Anda M., Lu, Binfeng, Oesterreich, Steffi, Davidson, Nancy E., Huang, Yi
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6336685/
https://ncbi.nlm.nih.gov/pubmed/30111819
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0451-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados